ABLYX
Price
$28.95
Change
-$0.16 (-0.55%)
Updated
Oct 7 closing price
Net Assets
3.46B
RMFCX
Price
$62.10
Change
-$0.10 (-0.16%)
Updated
Oct 7 closing price
Net Assets
112.6B
Interact to see
Advertisement

ABLYX vs RMFCX

Header iconABLYX vs RMFCX Comparison
Open Charts ABLYX vs RMFCXBanner chart's image
American Beacon Large Cap Value Y
Price$28.95
Change-$0.16 (-0.55%)
VolumeN/A
Net Assets3.46B
American Funds American Mutual R3
Price$62.10
Change-$0.10 (-0.16%)
VolumeN/A
Net Assets112.6B
ABLYX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
ABLYX vs. RMFCX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABLYX is a Buy and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 113B vs. ABLYX (3.47B). ABLYX pays higher dividends than RMFCX: ABLYX (1.52) vs RMFCX (1.20). ABLYX was incepted earlier than RMFCX: ABLYX (16 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than ABLYX (0.73). RMFCX is a more actively managed with annual turnover of: 31.00 vs. ABLYX (26.00). RMFCX has a lower initial minimum investment than ABLYX: RMFCX (250) vs ABLYX (100000). RMFCX annual gain was more profitable for investors over the last year : 8.11 vs. ABLYX (0.31). RMFCX return over 5 years is better than : 59.28 vs. ABLYX (27.46).
ABLYXRMFCXABLYX / RMFCX
Total Expense Ratio0.730.9180%
Annual Report Gross Expense Ratio0.730.9180%
Fund Existence16 years23 years-
Gain YTD12.13414.77982%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.47B113B3%
Annual Yield % from dividends1.521.20126%
Returns for 1 year0.318.114%
Returns for 3 years25.7043.6159%
Returns for 5 years27.4659.2846%
Returns for 10 years14.8793.9016%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXEO8.341.87
+28.90%
Lexeo Therapeutics
FRMEP25.74-0.06
-0.23%
First Merchants Corp
VMI397.23-3.13
-0.78%
Valmont Industries
UFPT196.98-4.95
-2.45%
UFP Technologies
KPTI5.77-0.39
-6.33%
Karyopharm Therapeutics Inc.